// App-Quantinova.ai

O24 : Concomitant treatment with MTX does not increase the efficacy of ustekinumab or TFNi in PsA: results from the PsABio study

Researchers

Presenter

  • Stefan Siebert

Principal Investigators

  • Elisa Gremese

  • Paul Bergmans

  • Kurt de Vlam

  • Beatriz Joven-Ibez

  • Gkikas Katsifis

  • Tatiana V Korotaeva

  • Wim Nol

  • Carlo Selmi

  • Petros P Sfikakis

  • Pavel Smirnov

  • Elke Theander

  • Michael T Nurmohamed

  • Laure Gossec

  • Josef S Smolen

Medical Centers

  • Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK

  • Fondazione Policlinico Gemelli, Università Cattolica del Sacro Cuore, Rome, ITALY

  • Clinical Biostatistics, Janssen, Breda, NETHERLANDS

  • Department of Hematology, University Hospital Leuven, Leuven, Belgium

  • Department of Rheumatology, Hospital 12 de Octubre, Madrid, SPAIN

  • Rheumatology Department, Naval Hospital of Athens, Athens, GREECE

  • VA Nasonova, Research Institute of Rheumatology, Moscow, RUSSIAN FEDERATION

  • Medical Affairs, Janssen, Brussels, BELGIUM

  • Rheumatology and Clinical Immunology, Humanitas Research Hospital, Rozzano, Italy

  • First Department of Propaedeutic Internal Medicine and Rheumatology, University of Athens, Athens, GREECE

  • Medical Affairs, Janssen, Moscow, RUSSIAN FEDERATION

  • Medical Affairs, Janssen, Solna, SWEDEN

  • Reade, and VU Rheumatology Research Department, Amsterdam, NETHERLANDS

  • Sorbonne Université, and Hôpital Pitié-Salpêtrière, Paris, FRANCE

  • Rheumatology, Medical University Vienna, Vienna, -

Locations

  • United Kingdom

  • Italy

  • Netherlands

  • Belgium

  • Spain

  • Greece

  • Russia

  • Sweden

  • France

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Dermatology

  • Musculoskeletal

Disease

  • Psoriatic arthritis

Biomarkers

  • Malondialdehyde

Drug/Treatment

  • Ustekinumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT02627768

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved